Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2019.101909
Abstract: OBJECTIVE This meta-analysis investigated the effectiveness of PARP inhibitors (PARPis) as maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC), stratifying results based on BRCA mutational status into five different categories: whole population, germ-line BRCA…
read more here.
Keywords:
maintenance treatment;
brca mutational;
analysis;
treatment platinum ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.02.039
Abstract: OBJECTIVE AURELIA, a randomized phase III trial of adding bevacizumab (B) to single agent chemotherapy (CT) for the treatment of platinum-resistant recurrent ovarian cancer, demonstrated improved progression free survival (PFS) in the B+CT arm compared…
read more here.
Keywords:
platinum resistant;
single agent;
treatment platinum;
cost ... See more keywords